Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance

Schneider, Rémi; Näpflin, Markus; Syrogiannouli, Lamprini; Bissig, Sarah; Tal, Kali; Bulliard, Jean‐Luc; Ducros, Cyril; Senn, Oliver; Selby, Kevin; Bähler, Caroline; Blozik, Eva; Auer, Reto

doi:10.3389/ijph.2021.1604073

Cited by 4 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, our claims data omitted inpatient tests. We had earlier estimated in another claims dataset that between 3.5 and 5% of colonoscopies in Switzerland are performed on inpatients ( Schneider et al, 2021 ). When conducting additional estimations with this data, we found that in Uri, inpatient colonoscopies accounted for 7.4% of colonoscopies.…”

Section: Discussionmentioning

confidence: 99%

Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018

Bissig

Syrogiannouli²,

Schneider³

et al. 2022

Preventive Medicine Reports

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018

Bissig

Syrogiannouli²,

Schneider³

et al. 2022

Preventive Medicine Reports

Self Cite

View full text Add to dashboard Cite

“…Previous studies have shown a clear socioeconomic gradient in colorectal cancer testing in Switzerland, with lower screening by younger citizens with high-deductible health plans [6,12]. We found that those participating in the screening programme were younger and healthier and had higher-deductible plans than those tested outside the programme.…”

Section: Discussionmentioning

confidence: 44%

“…They were (c) up to date with colonoscopy if they had undergone any colonoscopy in 2010-2018 and no faecal occult blood test in 2017-2018. Data were extracted from the Swiss Health Survey for comparison, using the methods described in a recent publication [12].…”

Section: Statistical Analysesmentioning

confidence: 99%

See 1 more Smart Citation

Colorectal cancer testing rates after implementation of an organised screening programme in Vaud, Switzerland

Hempel-Bruder¹,

Syrogiannouli²,

Schneider³

et al. 2023

Swiss Med Wkly

Self Cite

View full text Add to dashboard Cite

AIMS OF THE STUDY: Canton Vaud, Switzerland, implemented an organised colorectal cancer screening programme with colonoscopy and faecal occult blood tests in 2015, 4 to 6 years ahead of neighbouring cantons. Before its implementation, nearly half of Swiss citizens were already up to date with screening, primarily from opportunistic colonoscopies. We hypothesised that earlier implementation of an organised programme would be associated with greater increases in colorectal cancer testing rates. METHODS: We analysed Swiss health insurance claim data from CSS, a Swiss health insurer covering 16% of the Swiss population and 10% of canton Vaud. We stratified 50–69-year-olds into groups from Vaud, its four neighbouring cantons (Fribourg, Geneva, Neuchâtel and Valais), and the rest of Switzerland. We analysed overall, faecal occult blood test and colonoscopy testing rates for each year between 2010 and 2018. RESULTS: The overall testing rate increased from 7.6% in 2010 to 11.6% in 2018 (+4.0%) in Vaud, from 6.1% to 9.3% (+3.2%) in neighbouring cantons and from 7.4% to 8.6% (+1.2%) in the rest of Switzerland. The faecal occult blood test rate increased between 2016 and 2018 from 2.9% to 4.1% (+1.2%) in Vaud and from 1.7% to 2.6% (+0.9%) in neighbouring cantons, but it decreased from 3.1% to 1.5% (–1.6%) in the rest of Switzerland. The colonoscopy rate increased in all cantons, from 4.7% to 7.5% in Vaud (+2.8%), from 4.4% to 6.7% in neighbouring cantons (+2.3%) and from 4.3% to 7.1% in the rest of Switzerland (+2.8%). By 2018, 40% of faecal occult blood tests and 26% of colonoscopies in Vaud occurred in the organised programme. Those who completed an faecal occult blood test within the Vaud programme were younger, had fewer comorbidities and were more likely to have a high-deductible health plan than those tested outside the programme. CONCLUSIONS: Colorectal cancer testing rates increased between 2010 and 2018, with greater absolute increases in Vaud than in neighbouring cantons or the rest of Switzerland. Faecal occult blood test use increased in both Vaud and neighbouring cantons, possibly reflecting changes in testing patterns by general practitioners. By 2018, 40% of colonoscopies and 26% of faecal occult blood tests occurred within the screening programme.

show abstract

“…However, the Helsana Group covers about 15% of the Swiss population from all patient groups and Swiss regions. Previous studies showed that the population is largely representative for the general population of Switzerland, and that feasibility testing based on this data is appropriate [ 27 – 29 ].…”

Section: Discussionmentioning

confidence: 99%

Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: update of the SQUIPRICA working group

Blozik

Farcher

Graber

et al. 2022

BMC Health Serv Res

Self Cite

View full text Add to dashboard Cite

Background The level of quality of care of ambulatory services in Switzerland is almost completely unknown. Since health insurance claims are the only nationwide applicable and available data source for this purpose, a set of 24 quality indicators (QI) for the measurement of quality of primary care has been previously developed and implemented. The present paper reports on an evidence-based update and extension of the initial QI set. Methods Established pragmatic 6-step process based on informal consensus and potential QI extracted from international medical practice guidelines and pre-existing QI for primary care. Experts rated potential QI based on strength of evidence, relevance for Swiss public health, and controllability in the Swiss primary care context. Feasibility of a preliminary set of potential new QI was tested using claims data of persons with basic mandatory health insurance at one of the largest Swiss health insurers. This test built the basis for expert consensus on the final set of new QI. Additionally, two diabetes indicators included in the previous QI set were re-evaluated. Results Of 23 potential new indicators, 19 of them were selected for feasibility testing. The expert group consented a final set of 9 additional QI covering the domains general aspects/efficiency (2 QI), diagnostic measures (1 QI), geriatric care (2 QI), osteoarthritis (1 QI), and drug safety (3 QI). Two pre-existing diabetes indicators were updated. Conclusions Additional QI relating to overuse and intersectoral care aspects extend the options of measuring quality of primary care in Switzerland based on claims data and complement the initial QI set.

show abstract

Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance

Cited by 4 publications

References 29 publications

Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018

Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018

Colorectal cancer testing rates after implementation of an organised screening programme in Vaud, Switzerland

Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: update of the SQUIPRICA working group

Contact Info

Product

Resources

About